Memantine Hydrochloride
- Product NDC
- 10370-349
- 11-digit product format
- 103700349
- Labeler code
- 10370
- Product ID
- 10370-349_84bb0482-3d0a-4f64-a2cb-865fe4becd6b
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Memantine Hydrochloride
- Dosage form
- CAPSULE, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Par Pharmaceutical, Inc.
- Application
- ANDA205784
- Marketing category
- ANDA
- Marketing start
- 2018-02-20
- Marketing end
- 2023-06-30
- Substance
- MEMANTINE HYDROCHLORIDE
- Active strength
- 28 mg/1
- Pharmacologic classes
- N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 10370-349-09 | 10370034909 | 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (10370-349-09) | 2018-02-20 | 0000-00-00 | No | No | Current |
| 10370-349-11 | 10370034911 | 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (10370-349-11) | 2018-02-20 | 0000-00-00 | No | No | Current |